BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 14637386)

  • 1. Advanced breast cancer: an update and controversies on diagnosis and therapy.
    Nicolini A; Carpi A
    Biomed Pharmacother; 2003 Dec; 57(10):439-46. PubMed ID: 14637386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Cardoso F; Fallowfield L; Costa A; Castiglione M; Senkus E;
    Ann Oncol; 2011 Sep; 22 Suppl 6():vi25-30. PubMed ID: 21908499
    [No Abstract]   [Full Text] [Related]  

  • 3. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of locally recurrent or metastatic breast cancer (MBC).
    Kataja VV; Colleoni M; Bergh J;
    Ann Oncol; 2005; 16 Suppl 1():i10-2. PubMed ID: 15888735
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment guideline for advanced or recurrent breast cancer].
    Watanabe T; Katsumata N; Saijo N
    Nihon Rinsho; 2000 Apr; 58 Suppl():237-45. PubMed ID: 11026001
    [No Abstract]   [Full Text] [Related]  

  • 5. Ipsilateral breast tumor recurrence as a predictor of distant disease: implications for systemic therapy at the time of local relapse.
    Haffty BG; Reiss M; Beinfield M; Fischer D; Ward B; McKhann C
    J Clin Oncol; 1996 Jan; 14(1):52-7. PubMed ID: 8558220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of Care and Clinical Outcomes of HER2-positive Metastatic Breast Cancer Patients With Newly Diagnosed Stage IV or Recurrent Disease Undergoing First-line Trastuzumab-based Therapy: A Multicenter Retrospective Cohort Study.
    Lambertini M; Ferreira AR; Di Meglio A; Poggio F; Puglisi F; Sottotetti F; Montemurro F; Poletto E; Bernardo A; Risi E; Dellepiane C; Sini V; Minuti G; Grasso D; Fancelli S; Del Mastro L
    Clin Breast Cancer; 2017 Dec; 17(8):601-610.e2. PubMed ID: 28479052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: a retrospective clinical study.
    Sanpaolo P; Barbieri V; Genovesi D
    Eur J Surg Oncol; 2011 Oct; 37(10):876-82. PubMed ID: 21824742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors for male breast cancer: similarity to female counterparts.
    Yu E; Stitt L; Vujovic O; Joseph K; Assouline A; Au J; Younus J; Perera F; Tai P
    Anticancer Res; 2013 May; 33(5):2227-31. PubMed ID: 23645780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The long-term prognosis of locally recurrent breast cancer after breast conserving treatment].
    Voogd AC; Rutgers EJ; van Tienhoven G
    Ned Tijdschr Geneeskd; 2006 Jan; 150(1):29-33. PubMed ID: 16440622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical predictors of long-term survival in HER2-positive metastatic breast cancer.
    Murthy P; Kidwell KM; Schott AF; Merajver SD; Griggs JJ; Smerage JD; Van Poznak CH; Wicha MS; Hayes DF; Henry NL
    Breast Cancer Res Treat; 2016 Feb; 155(3):589-95. PubMed ID: 26875184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Locoregional recurrence of breast cancer: a retrospective comparison of treatment methods.
    Skowronek J; Piotrowski T
    Neoplasma; 2002; 49(6):426-31. PubMed ID: 12584593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Locoregionally recurrent breast cancer: incidence, risk factors and survival.
    Clemons M; Danson S; Hamilton T; Goss P
    Cancer Treat Rev; 2001 Apr; 27(2):67-82. PubMed ID: 11319846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local radiotherapy alone following neoadjuvant chemotherapy and surgery in combined clinical stage II and III breast cancer.
    White R; Dinneen T; Makris A
    Radiat Oncol; 2016 Jul; 11():93. PubMed ID: 27457764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer?
    Lobbezoo DJ; van Kampen RJ; Voogd AC; Dercksen MW; van den Berkmortel F; Smilde TJ; van de Wouw AJ; Peters FP; van Riel JM; Peters NA; de Boer M; Peer PG; Tjan-Heijnen VC
    Br J Cancer; 2015 Apr; 112(9):1445-51. PubMed ID: 25880008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Survival and Cure in Distant Metastatic Breast Cancer.
    Güth U; Elfgen C; Montagna G; Schmid SM
    Oncology; 2019; 97(2):82-93. PubMed ID: 31055570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiotherapy for patients with unresected locally advanced breast cancer.
    Yee C; Alayed Y; Drost L; Karam I; Vesprini D; McCann C; Soliman H; Zhang L; Chow E; Chan S; Lee J
    Ann Palliat Med; 2018 Oct; 7(4):373-384. PubMed ID: 30180725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical course of recurrent and metastatic disease in breast cancer].
    Koffmann B; Baez MR
    Rev Med Chil; 1991 Apr; 119(4):423-7. PubMed ID: 1842986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can Locoregionally Recurrent Breast Cancer Be Cured?
    Chand AR; Ziauddin MF; Tang SC
    Clin Breast Cancer; 2017 Aug; 17(5):326-335. PubMed ID: 28365334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic factors of metastatic breast cancer--2].
    Brockmann B; Reitzig P; Dietzmann A; Cyganiak P
    Z Arztl Fortbild (Jena); 1994 Apr; 88(4):305-9. PubMed ID: 8053233
    [No Abstract]   [Full Text] [Related]  

  • 20. Hyperthermia and radiation therapy for locally advanced or recurrent breast cancer.
    Refaat T; Sachdev S; Sathiaseelan V; Helenowski I; Abdelmoneim S; Pierce MC; Woloschak G; Small W; Mittal B; Kiel KD
    Breast; 2015 Aug; 24(4):418-25. PubMed ID: 25900383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.